Sandalan, Proceso D.
HRN: 03-57-23 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2023
CEFUROXIME 500MG (TAB)
09/29/2023
10/06/2023
PO
500mg
Q12hr
Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes